Skip to content
  • Solutions
    Solutions
    • Overview
    • TrypsiNNex®
      • TrypsiNNex® applications
      • TrypsiNNex® FAQ
    • Recombinant Insulin
      • Insulin applications
      • Insulin FAQ
      • Insulin 10 reasons why
    • Benzalkonium Chloride (BKC)
      • BKC applications
      • BKC FAQ
      • BKC 10 reasons why
    • Product list
  • Resources
    Resources
    • Overview
    • TrypsiNNex® insights
      • Application notes
      • Webinars and videos
      • Posters and infographics
    • Insulin insights
      • Application notes and case studies
      • Posters and infographics
      • Webinars and presentations
      • E-book
      • Insulin learnings
    • BKC insights
      • Whitepapers
      • Webinars and videos
      • BKC learnings
      • Scientific resources
    • SDS documents
      • TrypsiNNex®
      • Recombinant Insulin
      • Benzalkonium Chloride 
  • Company
    • Overview
    • About us
      • We are enablers
      • Values
      • Management
      • Board of Directors
    • Collaboration
    • Valuechain
      • Annual report 2024
  • Career
  • Sustainability
    • Overview
    • Environment
    • Social
    • Governance
  • Contact
    Contact
    • Overview
    • Let’s get in touch
    • Request sample​
    • Request quotation
    • Distributors and agents
  • Search
    Filter by content type
    Choose One/Select all
    Taxonomy terms

    Try these: Benzalkonium ChlorideRecombinant InsulinTrypsiNNexInsightsSDS documentsCase StudyWhite paper

nnp_web-logo_large
Menu
  • Solutions
    • Overview
    • TrypsiNNex®
      •  TrypsiNNex®
      • TrypsiNNex® FAQ
      • TrypsiNNex® applications
    • Recombinant Insulin
      • Recombinant Insulin
      • Insulin applications
      • Insulin FAQ
      • Insulin 10 reasons why
    • Benzalkonium Chloride
      • Benzalkonium Chloride (BKC)
      • BKC applications
      • BKC FAQ
      • BKC 10 reasons why
    • Products
  • Resources
    • Overview
    • Insulin insights
    • BKC insights
    • SDS Documents
  • Career
  • Company
    • Overview
    • About us
    • Collaboration
    • Management
    • Annual report
    • Values
    • Valuechain
  • Sustainability
    • Overview
    • Environment
    • Social
    • Governance
  • Contact
    • Overview
    • Let’s get in touch
    • Request sample​
    • Request quotation
    • Distributors and agents
  • Search

Category: Cell-based vaccines

Boosting influenza virus production in HEK293 cells with Recombinant Insulin

Cell-based vaccinees

Boosting VLP production in Sf9 cells with Recombinant Insulin

Cell-based vaccinees

Novo Nordisk Pharmatech

Københavnsvej 216
4600 Køge,
Denmark
+45 5667 1000
[email protected]

CVR-no. 13246149

Other links

  • News
  • Events
  • Let’s get in touch
  • Request sample​
  • Request quotation
  • MaxPartner platform
  • News
  • Events
  • Let’s get in touch
  • Request sample​
  • Request quotation
  • MaxPartner platform

Company

  • About us
  • Collaboration
  • Management
  • Valuechain
  • Values
  • Annual report 2024
  • About us
  • Collaboration
  • Management
  • Valuechain
  • Values
  • Annual report 2024
© 2025 Novo Nordisk Pharmatech A/S
  • General terms and conditions
  • Privacy policy
  • Cookie policy
  • General terms and conditions
  • Privacy policy
  • Cookie policy